Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats

Clinical and Experimental Pharmacology and Physiology

Volumn 42, Issue 1, 2015, Pages 63-68

  Ghadiri Soufi, Farhad ^a   Arbabi Aval, Elham ^b   Rezaei Kanavi, Mozhgan ^b   Ahmadieh, Hamid ^b  

^a HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic retinopathy; Nuclear factor B; Polyphenol; Resveratrol; Streptozotocin nicotinamide model

Indexed keywords

GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESSENGER RNA; NICOTINAMIDE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; GLUCOSE BLOOD LEVEL; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; RETINA; WEIGHT REDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; INFLAMMATION MEDIATORS; INSULIN; MALE; RATS; RATS, WISTAR; RETINA; STILBENES;

EID: 84919683050     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12326     Document Type: Article

References (61)

1. Tomić M, Ljubić S, Kaštelan S, Gverović Antunica A, Jazbec A, Poljičanin T. Inflammation, haemostatic disturbance, and obesity: Possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm. 2013; 2013: 8 18 671.
2. Palsamy P, Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol. 2010; 224: 423-32.
3. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br. J. Ophthalmol. 2002; 86: 363-5.
4. Haubner F, Lehle K, Munzel D et al. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell. Biochem. Biophys. Res. Commun. 2007; 360: 560-5.
5. Tawfik A, Sanders T, Kahook K et al. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: Role of NADPH oxidase. Invest. Ophthalmol. Vis. Sci. 2009; 50: 878-84.
6. Miyamoto K, Ogura Y. Pathogenetic potential of leukocytes in diabetic retinopathy. Semin. Ophthalmol. 1999; 14: 233-9.
7. Yuuki T, Kanda T, Kimura Y et al. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J. Diabetes Complications 2001; 15: 257-9.
8. Joussen AM, Poulaki V, Le ML et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004; 18: 1450-2.
9. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. L-arginine transport in retinas from streptozotocin diabetic rats: Correlation with the level of IL-1 beta and NO synthase activity. Vision. Res. 1999; 39: 3817-23.
10. Malchiodi-Albedi F, Matteucci A, Bernardo A, Minghetti L. PPAR-gamma, microglial cells, and ocular inflammation: New venues for potential therapeutic approaches. PPAR Res. 2008; 2008: 295784.
11. Lee JH, Song MY, Song EK et al. Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappa B signaling pathway. Diabetes 2009; 58: 344-51.
12. Joussen AM, Doehmen S, Lee ML, et al. TNF-α mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations. Mol. Vis. 2009; 15: 1418-28.
13. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 2001; 158: 147-52.
14. Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am. J. Ophthalmol. 1970; 69: 403-14.
15. Barouch FC, Miyamoto K, Allport JR et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest. Ophthalmol. Vis. Sci. 2000; 41: 1153-8.
16. Soufi FG, Mohammad-Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway. Pharmacol. Rep. 2012; 64: 1505-14.
17. Boileau TW, Bray TM, Bomser JA. Ultraviolet radiation modulates nuclear factor kappa B activation in human lens epithelial cells. J. Biochem. Mol. Toxicol. 2003; 17: 108-13.
18. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 1994; 10: 405-55.
19. Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 1997; 17: 3-9.
20. Chen W, Esselman WJ, Jump DB, Busik JV. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci. 2005; 46: 4342-7.
21. Joussen AM, Poulaki V, Qin W et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 2002; 160: 501-9.
22. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic. Res. 2003; 37: 1169-80.
23. Palsamy P, Subramanian S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin -nicotinamide-induced experimental diabetic rats. Biomed. Pharmacother. 2008; 62: 598-605.
24. Csiszar A. Anti-inflammatory effects of resveratrol: Possible role in prevention of age-related cardiovascular disease. Ann. N. Y. Acad. Sci. 2011; 1215: 117-22.
25. Ungvari Z, Orosz Z, Rivera A et al. Resveratrol increases vascular oxidative stress resistance. Am. J. Physiol. 2007; 292: H2417-24.
26. Ungvari Z, Bagi Z, Feher A et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H18-24.
27. Lee SM, Yang H, Tartar DM et al. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia 2011; 54: 1136-46.
28. Sharma SS, Kumar A, Arora M, Kaundal PK. Neuroprotective potential of combination of resveratrol and 4-amino 1, 8 naphthalimide in experimental diabetic neuropathy: Focus on functional, sensorimotor and bio chemical changes. Free Radic. Res. 2009; 43: 400-8.
29. Sharma S, Misra CS, Arumugam S et al. Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytother. Res. 2011; 25: 67-73.
30. Zhang H, Morgan B, Potter BJ et al. Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: In vivo demonstration with magnetic resonance imaging. Am. J. Physiol. Heart Circ. Physiol. 2010; 299: H985-94.
31. Kubota S, Ozawa Y, Kurihara T et al. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest. Ophthalmol. Vis. Sci. 2011; 52: 9142-8.
32. Kubota S, Kurihara T, Mochimaru H et al. Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest. Ophthalmol. Vis. Sci. 2009; 50: 3512-19.
33. Sharma KR, Bhatia RP, Kumar V. Role of the indigenous drug saptamrita lauha in hemorrhagic retinopathies. Ann. Ophthalmol. 1992; 24: 5-8.
34. Ma ZH, Ma QY, Wang LC, Sha HC, Wu SL, Zhang M. Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm. Res. 2005; 54: 522-7.
35. Meng Y, Ma QY, Kou XP, Xu J. Effect of resveratrol on activation of nuclear factor kappa-B and inflammatory factors in rat model of acute pancreatities. World J. Gastroenterol. 2005; 11: 525-8.
36. Li ZD, Ma QY, Wang CA. Effect of resveratrol on pancreatic oxygen free radicals in rats with severe acute pancreatitis. World J. Gastroenterol. 2006; 12: 137-40.
37. Szabolcs A, Varga IS, Varga C et al. Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitis. Eur. J. Pharmacol. 2006; 532: 187-93.
38. Akar F, Pektas MB, Tufan C et al. Resveratrol shows vasoprotecive effect reducing oxidative stress without affecting metabolic disturbances in insulin-dependent diabetes of rabbits. Cardiovasc. Drugs Ther. 2011; 25: 119-31.
39. Roghani M, Baluchnejadmojarad T. Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats. Phytother. Res. 2010; 24 (Suppl 2): S148-54.
40. Yun JM, Chien A, Jialali I, Devaraj S. Resveratrol upregulates SRIT1 and inhibits cellular oxidative stress in the diabetic milieu. Mechanistic insights. J. Nutr. Biochem. 2012; 23 (Suppl 2): 699-705.
41. Kumar A, Kaundal RK, Iyer S, Sharma SS. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 2007; 80: 1236-44.
42. Hardie DG. AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 2007; 8: 774-85.
43. Hattori Y, Suzuki K, Tomizawa A et al. Cilostazol inhibits cytokine-induced nuclear factor-kappa B activation via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovasc. Res. 2009; 81: 133-9.
44. Nagai N, Izumi-Nagai K, Oike Y et al. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest. Ophthalmol. Vis. Sci. 2007; 48: 4342-50.
45. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: Evidence for an adipose tissue-vascular loop. Arterioscler. Thromb. Vasc. Biol. 2008; 28: 1368-74.
46. Yang Z, Kahn BB, Shi H, Xue BZ. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 2010; 285: 19051-9.
47. Zhao X, Zmijewski JW, Lorne E et al. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 295: L497-504.
48. Yang T, Fu M, Pestell R, Sauve AA. SIRT1 and endocrine signaling. Trends Endocrinol. Metab. 2006; 17: 186-91.
49. Michan S, Sinclair D. Sirtuins in mammals: Insights into their biological function. Biochem. J. 2007; 404: 1-13.
50. Luo J, Nikolaev AY, Imai S et al. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 2001; 107: 137-48.
51. Hofmann MA, Schiekofer S, Kanitz M et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patient with type 1 diabetes. Diabetes Care 1998; 21: 1310-16.
52. Palsamy P, Subramanian S. Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chem. Biol. Interact. 2009; 179: 356-62.
53. Song MK, Roufogalis BD, Huang TH. Modulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology. Br. J. Pharmacol. 2012; 165: 4-19.
54. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J. Nutr. Biochem. 2005; 16: 705-13.
55. Leal EC, Aveleira CA, Castilho AF et al. High glucose and oxidative/nitrosative stress conditions induce apoptosis in retinal endothelial cells by a caspase-independent pathway. Exp. Eye Res. 2009; 88: 983-91.
56. Doonan F, Wallace DM, O'Driscoll C, Cotter TG. Rosiglitazone acts as a neuroprotectant in retinal cells via up-regulation of sestrin-1 and SOD-2. J. Neurochem. 2009; 109: 631-43.
57. Islam MS, Wilson RD. Experimentally induced rodent models of type 2 diabetes. Methods Mol. Biol. 2012; 933: 161-74.
58. Szkudelski T. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp. Biol. Med. (Maywood) 2012; 237: 481-90.
59. Islam MS, du Loots T. Experimental rodent models of type 2 diabetes: A review. Methods Find. Exp. Clin. Pharmacol. 2009; 31: 249-61.
60. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J. Clin. Pathol. 1969; 22: 158-61.
61. Fink T, Lund P, Pilgaard L, Rasmussen JG, Duroux M, Zachar V. Instability of standard PCR reference genes in adipose derived stem cells during propagation, differentiation and hypoxic exposure. BMC Mol. Biol. 2008; 9: 98.